Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

153.24 -6.58 (-4.12%)
Official Closing Price Updated: 7:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,603,861
Open 159.16
Bid (Size) 153.53 (3)
Ask (Size) 155.17 (1)
Prev. Close 159.82
Today's Range 152.93 - 159.82
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 3.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sit Out Market Drama With These 3 Dividend Funds
Via Benzinga
Johnson & Johnson's Tremfya Shows Efficacy In Late-Stage Psoriatic Arthritis Study
Johnson & Johnson's Phase 3b APEX study shows Tremfya reduces symptoms and structural damage in psoriatic arthritis patients with no new safety concerns. 
Via Benzinga

Performance

YTD
+6.4%
+6.4%
1 Month
-7.2%
-7.2%
3 Month
+6.3%
+6.3%
6 Month
-4.4%
-4.4%
1 Year
+0.5%
+0.5%

More News

Read More
Trump's Tariff Exemptions Include Semiconductors, Pharmaceuticals, Oil And More
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Man With $30K To Deploy Wants Dividends For Life – 'Even If It's Just Enough To Pay For A Yearly Vacation Here Or There,' Reddit Reacts
Via Benzinga
Topics Retirement
Exposures Pension
Worried About the Economy? 2 No-Brainer Buys to Shield Your Portfolio.
Via The Motley Fool
Topics Earnings Economy Government
Exposures Economy Financial Interest Rates
What 13 Analyst Ratings Have To Say About Johnson & Johnson
Via Benzinga
Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended
Via Benzinga
Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
From Johnson & Johnson
Via Business Wire
J&J Retail Traders Unfazed By Court Rejecting 3rd Talc Settlement, But Analyst Sees Stock Pullback Risk
Via Stocktwits
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Newsmax, Waton Financial, Johnson & Johnson, Hims & Hers Health, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Stock Is Tumbling Tuesday: What Going On?
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Why Johnson & Johnson Stock Is Sinking Today
Via The Motley Fool
Topics Bankruptcy Lawsuit Stocks
Exposures Financial Legal US Equities
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Stocks Edge Higher Despite Trade, Economic Jitters
Via Talk Markets
Topics Stocks / Equities
Wall Street Inches Up Ahead Of Tariff Day: What's Driving Markets Tuesday?
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
These S&P500 stocks are gapping in today's session
Via Chartmill
Why Johnson & Johnson (JNJ) Shares Are Falling Today
Via StockStory
Topics Bankruptcy Lawsuit
Exposures Financial Legal
US Manufacturing Slips Into Contraction As Tariff-Driven Costs Hit Near 3-Year High
Via Benzinga
These S&P500 stocks are moving in today's pre-market session
Via Chartmill
J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bankruptcy Plan
Via Investor's Business Daily
Topics Bankruptcy Lawsuit
Exposures Financial Legal
US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Federal Judge Rejects Johnson & Johnson Bankruptcy Strategy, Paving Way for Talc Victims to Seek Justice in Trial Courts
From Beasley Allen Law Firm
Via Business Wire
2 Value Stocks I'm Buying Right Now
Via The Motley Fool
Topics Economy
Exposures Interest Rates

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 153.24
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/04/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 402.82B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 403B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.